Standout Papers
Immediate Impact
10 from Science/Nature 56 standout
Citing Papers
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
2025 Standout
Natural killer cell therapies
2024 StandoutNature
Works of Kenneth R. Carson being referenced
A drug safety evaluation of rituximab and risk of hepatitis B
2014
A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma
2011
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Kenneth R. Carson | 1893 | 873 | 705 | 145 | 4.1k | |
| Gerard Vreugdenhil | 3092 | 656 | 885 | 160 | 4.9k | |
| Rafael Marcos‐Gragera | 2096 | 1000 | 617 | 170 | 4.3k | |
| Bhawna Sirohi | 1621 | 422 | 1170 | 166 | 3.7k | |
| Ralph M. Meyer | 1666 | 1789 | 1427 | 138 | 4.6k | |
| Vijaya Raj Bhatt | 1383 | 307 | 898 | 238 | 3.0k | |
| Gerlinde Egerer | 1340 | 873 | 1219 | 178 | 4.5k | |
| James A. Kaye | 1141 | 378 | 1074 | 168 | 5.1k | |
| Glenn Mills | 1812 | 557 | 415 | 117 | 3.2k | |
| Vincent Lévy | 1250 | 1235 | 821 | 186 | 5.2k | |
| Mark A. Weiss | 1009 | 658 | 824 | 148 | 5.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...